pOPINB-hRNF216(511-784)
(Plasmid
#171923)
-
PurposeExpression of human RNF216 (Triad3A) codon optimized for E. coli and insect cells. Catalytic RBR-helix construct suitable for activity assays.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 171923 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepOPINB
- Backbone size w/o insert (bp) 5642
- Total vector size (bp) 7908
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameE3 ubiquitin-protein ligase RNF216
-
Alt nameRNF216
-
Alt nameTRIAD3A
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2633
-
Mutationcodon optimised for expression in E. coli
-
GenBank IDNM_207116
-
Entrez GeneRNF216 (a.k.a. CAHH, TRIAD3, U7I1, UBCE7IP1, ZIN)
- Promoter T7
-
Tags
/ Fusion Proteins
- 6x-His tag (N terminal on backbone)
- 3C protease cleavage site (N terminal on backbone)
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer T7
- 3′ sequencing primer T7 Terminal (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pOPINB-hRNF216(511-784) was a gift from Bernhard Lechtenberg (Addgene plasmid # 171923 ; http://n2t.net/addgene:171923 ; RRID:Addgene_171923) -
For your References section:
Structural basis of K63-ubiquitin chain formation by the Gordon-Holmes syndrome RBR E3 ubiquitin ligase RNF216. Cotton TR, Cobbold SA, Bernardini JP, Richardson LW, Wang XS, Lechtenberg BC. Mol Cell. 2022 Feb 3;82(3):598-615.e8. doi: 10.1016/j.molcel.2021.12.005. Epub 2022 Jan 7. 10.1016/j.molcel.2021.12.005 PubMed 34998453